v
Search
Advanced Search

Publications > Journals > Cancer Screening and Prevention > Article Full Text

  • OPEN ACCESS

Preoperative Evaluation of the Renal Function Before Kidney Cancer Surgery

  • Tao-Nong Cai1,2,3,
  • Jiang-Li Lu1,2,3,
  • Zi-Ke Qin1,2,3 and
  • Yun-Lin Ye1,2,3,* 
 Author information
Cancer Screening and Prevention   2023;2(3):173-176

doi: 10.14218/CSP.2023.00025

Abstract

Renal function is the basic focus of examination before kidney cancer surgery and determines the choice of surgery procedure. The prediction of renal function after surgery may also affect the surgical method, and it will certainly affect the prognosis of the patient. Herein, we provide a review of the relevant literature on partial nephrectomy (PN) and radical nephrectomy (RN) respectively, discuss methods for estimating kidney function, and compare effects. We found that the most reliable way to predict new baseline glomerular filtration rate (GFR) after PN was the quantitative estimation of the Percent of Preserved Parenchymal Mass (PPPM), while the simplest way to predict new-baseline GFR after RN was derivation from contralateral kidney, with ≥45 mL/min/1.73 m2 considered a good cutoff to evaluate the kidney function and survival outcomes. In addition, based on AI, the imaging-guided analysis would provide a feasible, simple, and reliable prediction model.

Keywords

Renal function, Partial nephrectomy (PN), Radical nephrectomy (RN), Glomerular filtration rate (GFR)

Introduction

In renal cancer surgery, kidney function is one of the most fundamental topics during preoperative counseling. When it is technically feasible, partial nephrectomy (PN) is recommended for clinical T1 renal tumors for its oncologic equivalence to radical nephrectomy (RN), while radical nephrectomy is essential when there could be one of several consequences, for example, carcinoma of kidney pelvis and complex renal tumor with normal contralateral kidney.1,2 In this clinical dilemma, effective kidney function prediction is of significant importance.

In several large-population studies, kidney function was reported to be associated with non-cancer mortality and cancer-specific survival. In their meta-analysis, Simon et al. (2012) suggested that partial nephrectomy conferred a lower risk of chronic kidney disease (HR 0.39, p < .001) and a survival advantage (HR 0.81, p < 0.001).3 Antonelli and his colleagues also demonstrated that cancer-specific mortality was associated with estimated glomerular filtration rates (eGFR) when they were below the cutoffs, and renal function should be preserved to improve cancer-related survival.4 On the other hand, some recent investigations revealed that kidney function was not associated with cancer-specific mortality. Moreover, Gershman et al. (2018) revealed that radical nephrectomy was associated with an increased risk of chronic kidney disease but not with cancer-specific mortality or all-cause mortality.5 And in the unique prospective research (EORTC 30904), PN achieved better kidney function and was not associated with better survival outcomes.6,7 Campbell and his team found that patients with a new baseline glomerular filtration rate (NBGFR) ≥45 mL/minute/1.73 m2 had a better survival outcome and an increased NBGFR above this cutoff was not correlated with a better survival outcome.8 Furthermore, their recent research confirmed that kidney function was not associated with cancer-specific survival, and an increased preoperative eGFR was associated with reduced all-cause mortality.9

However, the significance of kidney function for survival is still in debate but whatever the outcome, effective kidney function prediction remains important during clinical management of kidney tumors. If a higher GFR is required, PN should be performed if feasible. If the contralateral kidney had enough GFR, PN or RN would not be a difficult decision for a complicated renal mass. In this review, we will analyze the most popular methods of kidney function prediction and compare their effects. In PN cases, parenchymal volume preservation is the most important part of renal function preservation, while in RN cases, the compensation of the contralateral kidney is critical to new-baseline kidney function. Thus, we divided the review into two parts; the first one is focused on PN and the other on RN.

Kidney function prediction for patients undergoing PN

In PN cases, if the ischemia time is limited (less than 30 min), parenchymal volume preservation is at the center of kidney function prediction. Until now, the Percent of Preserved Parenchymal Mass (PPPM) has been the most reliable and reasonable method of predicting new-baseline kidney function. However, once AI based on a 3D reconstruction system can calculate the volume of parenchymal loss, it will provide a feasible, simple, and objective method and Dr. Campbell from Cleveland Clinic has already presented his initial work on this topic.10 If the ischemia time is extended, kidney function recovery must be taken into consideration. As reported, every minute above 30 min would affect recovery from ischemia.11 The compensation of the contralateral kidney has proven limited and not significant. A new method combining PPPM and an extended ischemia time should be developed and evaluated for efficacy above that of PPPM alone. Based on parenchymal volume preservation, several methods have been developed to predict postoperative kidney function or new-baseline kidney function.

It has been reported that PPPM is strongly associated with postoperative kidney function.12 Surgeon assessment of volume preservation before PN (subjective estimation of PPPM) and calculating parenchymal volume based on imaging (quantitative estimation PPPM) are reasonable estimates of functional renal volume preservation. Also, nephrometry scores such as RENAL—(R)adius, (E)xophytic/endophytic, (N)earness to collecting system/sinus, (A)nterior/posterior, and (L)ocation relative to polar lines—nephrometry, preoperative aspects and dimensions used for an anatomical classification (PADUA), centrality index (C-index), diameter-axial-polar (DAP), and contact surface area (CSA), which are scoring systems designed to quantify tumor complexity, are reported to be associated with kidney function preservation.13–17 As listed in Table S1, most scoring systems were modestly correlated with ipsilateral kidney function and only the DAP score had a favorable correlation to postoperative kidney function, but it was not validated in another cohort. Even for quantitative estimation (QE) PPPM, the correlation with ipsilateral kidney function was significant and modest (r = 0.46) although the correlation between QE PPPM and postoperative global renal function was strong (r=0.91).12 These results might reveal that the minor variation of ipsilateral kidney function had a limited impact on the total kidney function of patients with normal contralateral kidneys.

Besides the above methods, some prediction models have been developed based on regression analysis to predict new-baseline kidney function (listed in Table 1).18–22 In 2019, Mayo Clinic developed a new model to predict kidney function for patients undergoing renal surgery.23 For PN cases, age, solitary kidney, hypertension, preoperative eGFR, preoperative proteinuria, and surgical approach were associated with worse long-term renal function. The marginal and conditional R2 GLMM values of this model in predicting long-term renal function were 0.62 and 0.85. An external validation from Belgium demonstrated that early postoperative renal failure following PN and RN showed an AUC of 0.816 and 0.825 using the Mayo model and developed a new model to predict long-term renal function; the marginal and conditional R2 GLMM values were 0.591 and 0.855 for the PN cases, and 0.363 and 0.849 for the RN cases, respectively.24 However, both of these models were similar and suffered from being too complicated to perform in clinical practice. Aguilar Palacios D et al. from Cleveland Clinic also developed a simple model to predict new-baseline renal function. The accuracy of predicting renal function was 83% and 82% in internal and external validation. The AUC values to differentiate whether new-baseline renal function ≥45 mL/minute/1.73 m2 were 0.89 and 0.91 in internal and external validation.25 As we know, the new-baseline renal function ≥45 mL/minute/1.73 m2 was a critical cutoff in evaluating whether the renal function would affect overall survival and the prediction model seemed strong in evaluating perioperative kidney function.

Table 1

Several predicting models based on regression analysis

ResearchNo.EndpointsResultsVariables
Shum et al, 201718461eGFRsCoefficients of determination: 0.70age, race, sex, BMI, diabetes, HTN, IHD, stroke; preop. creatinine, preop. ipsilateral KV, SK; size
Bhindi et al, 2019191920eGFRsMarginal R2: 0.62age, DB, HTN preop. eGFR, PNU, SK
Martini et al, 20182099925% eGFR decreaseC index: 0.75age, CCI, sex, preop eGFR RENAL score
Bertolo et al, 2019211897NB-CKD stageAUC: 0.79age, sex, BMI, preop. CKD stage; RENAL score
Mari et al, 20222298125% eGFR decreaseAUC: 0.82age, sex, DB, CCI, peripheral vascular disease, preop. eGFR, PADUA score

Kidney function prediction for patients undergoing RN

Different from PN cases, all parenchymal masses in the ipsilateral kidney were removed with tumor. The prediction of new-baseline kidney function focused on the compensation of the contralateral kidney. In addition, some methods have been developed based on regression analysis to predict new-baseline kidney function.

Both Mayo Clinic and Cleveland Clinic have developed models to predict renal function after radical nephrectomy. In the Mayo Clinic’s model, older age, diabetes, lower preoperative eGFR, worse preoperative proteinuria, and smaller tumor size were associated with worse new-baseline renal function. The calculation method, however, is somewhat complicated.23 Moreover, they found that time from surgery interacted with a number of factors, which meant some comorbidity could affect kidney function in long-term follow-up and may not be derived from renal surgery.

In Cleveland Clinic’s model, the method of prediction of new-baseline renal function is simple. Based on split renal function from parenchymal volume analysis, the model focuses on the compensation of the contralateral kidney, which would be simple and consistent. They found that age (−0.85, p < 0.01), global preoperative estimated glomerular filtration rate (−0.28, p < 0.01), and split renal function of the removed kidney (0.61, p < 0.01) were independent predictors of renal function compensation. Based on these findings, they developed an equation to calculate the NBGFR: 35 + preoperative glomerular filtration rate (× 0.65) − 18 − age (× 0.25) + 3 (if tumor size >7 cm) − 2 (if diabetes).26 They then developed a new simple method of predicting new baseline eGFR: 1.24 × preoperative eGFR of the contralateral kidney. They compared this simple method with five other models that were not based on split renal function. The results revealed that the new equation based on split renal function and compensation offered a better prediction than the five other models, including their own models and those of Mayo.27,28

The compensation of the contralateral kidney in RN cases was associated with the primary renal function of each kidney and comorbidity, which was critical to recovery from ischemia and long-term postoperative kidney function in PN cases. The renal function of each kidney was easy to estimate, while the degree of each related comorbidity was difficult to calculate making it difficult to build a feasible and reliable model. Thus, a multicenter, large-populated prospective clinical trial should be performed to collect detailed comorbidity data and evaluate its effect on compensation and recovery from ischemia and long-term kidney function (Table 2).

Table 2

Kidney function prediction for patients underwent PN or RN

Surgical procedureTheoretical basesPredictive methods
PNIschemia time less than 30 minThe volume of parenchymal loss calculated by AI
Ischemia time more than 30 minSubjective estimation of PPPM and quantitative estimation of PPPM
RENAL, PADUA, C-index, DAP, CSA
Mayo model
Belgium model
Cleveland model
RNCompensation of contralateral kidneyMayo model
Cleveland model

Prospective

Until now, the simplest method of predicting new-baseline GFR after RN was derivation from the contralateral kidney, and the most reliable method after PN was a quantitative estimation of PPPM. In addition, some measures have also been reported as predictors of postoperative renal function, such as preoperative MR volumetry and perioperative blood transfusion.29,30 These metrics, although valid, have yet to be tested in terms of reliability in clinical use. At present, 3D reconstruction systems and AI are being widely applied in this field. We believe that with the help of different forecasting models, 3D reconstruction systems, and AI calculation, prediction will become quicker, more consistent, and simpler in the hopefully not-too-distant future.

Conclusions

To build a favorable model of predicting renal function was not simple. In some models, preoperative factors and postoperative factors were mixed, and the prediction value was confusing.31 In the meantime, the primary endpoint was also important for model building. In the early period, most research focused on calculating an exact value for kidney function, which was a continuous variable, and increased the complexity of prediction. In recent years, we have found that greater than 45 mL/minute/1.73 m2 is a good cutoff to evaluate kidney function and survival outcomes; calculating whether kidney function is >45 mL/minute/1.73 m2 seems a much better method. Moreover, based on AI, imaging-guided analysis would make a feasible, simple, and reliable prediction model.

Supporting information

Supplementary material for this article is available at https://doi.org/10.14218/CSP.2023.00025 .

Table S1

The renal function predicting values based on scoring systems of tumor complexity.

(DOCX)

Abbreviations

AI: 

artificial intelligence

C-index: 

centrality index

CSA: 

contact surface area

DAP: 

diameter-axial-polar

GFR: 

glomerular filtration rate

NBGFR: 

new baseline glomerular filtration rate

PADUA: 

preoperative aspects and dimensions used for an anatomical classification

PN: 

partial nephrectomy

PPPM: 

percent of preserved parenchymal mass

QE: 

quantitative estimation

RN: 

radical nephrectomy

Declarations

Acknowledgement

None.

Funding

None.

Conflict of interest

One of the authors, Dr. Yun-Lin Ye has been an editorial board member of Cancer Screening and Prevention since March 2022. The authors have no other conflict of interests.

Authors’ contributions

Contributed to study concept and design (TNC and YLY), acquisition of the data (JLL and YLY), assay performance and data analysis (TNC, JLL, ZKQ, and YLY), drafting of the manuscript (TNC and YLY), critical revision of the manuscript (YLY and ZKQ), supervision (YLY and ZKQ).

References

  1. Zhao W, Ding Y, Chen D, Xuan Y, Chen Z, Zhao X, et al. Comparison of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Patients with Completely Lower Pole Renal Tumors. J Clin Med 2023;12(2):722 View Article PubMed/NCBI
  2. Liu J, Tian C, Zhang Z, Zhou G, Shi B, Zhao H, et al. Correlation between preoperatively predicted and postoperatively observed renal function using an imaging-based approach: A retrospective cohort study. Oncol Lett 2020;20(1):501-508 View Article PubMed/NCBI
  3. Kim SP, Thompson RH, Boorjian SA, Weight CJ, Han LC, Murad MH, et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012;188(1):51-57 View Article PubMed/NCBI
  4. Antonelli A, Minervini A, Sandri M, Bertini R, Bertolo R, Carini M, et al. Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma. Eur Urol 2018;74(5):661-667 View Article PubMed/NCBI
  5. Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, et al. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. Eur Urol 2018;74(6):825-832 View Article PubMed/NCBI
  6. Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59(4):543-552 View Article PubMed/NCBI
  7. Scosyrev E, Messing EM, Sylvester R, Campbell S, Van Poppel H. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur Urol 2014;65(2):372-377 View Article PubMed/NCBI
  8. Suk-Ouichai C, Tanaka H, Wang Y, Wu J, Ye Y, Demirjian S, et al. Renal Cancer Surgery in Patients without Preexisting Chronic Kidney Disease-Is There a Survival Benefit for Partial Nephrectomy?. J Urol 2019;201(6):1088-1096 View Article PubMed/NCBI
  9. Palacios DA, Zabor EC, Munoz-Lopez C, Roversi G, Mahmood F, Abramczyk E, et al. Does Reduced Renal Function Predispose to Cancer-specific Mortality from Renal Cell Carcinoma?. Eur Urol 2021;79(6):774-780 View Article PubMed/NCBI
  10. Rathi N, Attawettayanon W, Yasuda Y, Lewis K, Roversi G, Shah S, et al. Point of care parenchymal volume analyses to estimate split renal function and predict functional outcomes after radical nephrectomy. Sci Rep 2023;13(1):6225 View Article PubMed/NCBI
  11. Dagenais J, Maurice MJ, Mouracade P, Kara O, Nelson RJ, Malkoc E, et al. The Synergistic Influence of Ischemic Time and Surgical Precision on Acute Kidney Injury After Robotic Partial Nephrectomy. Urology 2017;107:132-137 View Article PubMed/NCBI
  12. Tanaka H, Wang Y, Suk-Ouichai C, Palacios DA, Caraballo ER, Ye Y, et al. Can We Predict Functional Outcomes after Partial Nephrectomy?. J Urol 2019;201(4):693-701 View Article PubMed/NCBI
  13. Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Nephrometry score is associated with volume loss and functional recovery after partial nephrectomy. J Urol 2012;188(1):39-44 View Article PubMed/NCBI
  14. Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 2009;56(5):786-793 View Article PubMed/NCBI
  15. Simmons MN, Ching CB, Samplaski MK, Park CH, Gill IS. Kidney tumor location measurement using the C index method. J Urol 2010;183(5):1708-1713 View Article PubMed/NCBI
  16. Simmons MN, Hillyer SP, Lee BH, Fergany AF, Kaouk J, Campbell SC. Diameter-axial-polar nephrometry: integration and optimization of R.E.N.A.L. and centrality index scoring systems. J Urol 2012;188(2):384-390 View Article PubMed/NCBI
  17. Hsieh PF, Wang YD, Huang CP, Wu HC, Yang CR, Chen GH, et al. A Mathematical Method to Calculate Tumor Contact Surface Area: An Effective Parameter to Predict Renal Function after Partial Nephrectomy. J Urol 2016;196(1):33-40 View Article PubMed/NCBI
  18. Shum CF, Bahler CD, Cary C, Masterson TA, Boris RS, Gardner TA, et al. Preoperative Nomograms for Predicting Renal Function at 1 Year After Partial Nephrectomy. J Endourol 2017;31(7):711-718 View Article PubMed/NCBI
  19. Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, et al. Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75(5):766-772 View Article PubMed/NCBI
  20. Martini A, Cumarasamy S, Beksac AT, Abaza R, Eun DD, Bhandari A, et al. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy. Eur Urol 2018;74(6):833-839 View Article PubMed/NCBI
  21. Bertolo R, Garisto J, Li J, Dagenais J, Kaouk J. Development and Internal Validation of a Nomogram for Predicting Renal Function after Partial Nephrectomy. Eur Urol Oncol 2019;2(1):106-109 View Article PubMed/NCBI
  22. Mari A, Tellini R, Antonelli A, Porpiglia F, Schiavina R, Amparore D, et al. A Nomogram for the Prediction of Intermediate Significant Renal Function Loss After Robot-assisted Partial Nephrectomy for Localized Renal Tumors: A Prospective Multicenter Observational Study (RECORd2 Project). Eur Urol Focus 2022;8(4):980-987 View Article PubMed/NCBI
  23. Bhindi B, Lohse CM, Schulte PJ, Mason RJ, Cheville JC, Boorjian SA, et al. Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75(5):766-772 View Article PubMed/NCBI
  24. Roussel E, Laenen A, Bhindi B, De Dobbeleer A, Stichele AV, Verbeke L, et al. Predicting short- and long-term renal function following partial and radical nephrectomy. Urol Oncol 2023;41(2):110.e1-110.e6 View Article PubMed/NCBI
  25. Aguilar Palacios D, Wilson B, Ascha M, Campbell RA, Song S, DeWitt-Foy ME, et al. New Baseline Renal Function after Radical or Partial Nephrectomy: A Simple and Accurate Predictive Model. J Urol 2021;205(5):1310-1320 View Article PubMed/NCBI
  26. Aguilar Palacios D, Caraballo ER, Tanaka H, Wang Y, Suk-Ouichai C, Ye Y, et al. Compensatory Changes in Parenchymal Mass and Function after Radical Nephrectomy. J Urol 2020;204(1):42-49 View Article PubMed/NCBI
  27. Rathi N, Yasuda Y, Palacios DA, Attawettayanon W, Li J, Bhindi B, et al. Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy. Eur Urol Open Sci 2022;40:112-116 View Article PubMed/NCBI
  28. Rathi N, Palacios DA, Abramczyk E, Tanaka H, Ye Y, Li J, et al. Predicting GFR after radical nephrectomy: the importance of split renal function. World J Urol 2022;40(4):1011-1018 View Article PubMed/NCBI
  29. Favorito LA. Editorial Comment: Role of preoperative MR volumetry in patients with renal cell carcinoma for prediction of postoperative renal function after radical nephrectomy and nephron sparing surgery. Int Braz J Urol 2020;46(2):242-243 View Article PubMed/NCBI
  30. Mühlbauer J, de Gilde J, Mueller-Steinhardt M, Porubsky S, Walach M, Nuhn P, et al. Perioperative Blood Transfusion Is a Predictor of Acute and Chronic Renal Function Deterioration after Partial and Radical Nephrectomy for Renal Cell Carcinoma. Urol Int 2020;104(9-10):775-780 View Article PubMed/NCBI
  31. Jin D, Luo Y, Zhu H, Li Y, Huang Z, Zhang Y, et al. Development and validation of an integrated nomogram to predict personalized new baseline functional outcomes after partial nephrectomy. Transl Androl Urol 2022;11(1):9-19 View Article PubMed/NCBI
  • Cancer Screening and Prevention
  • pISSN 2993-6314
  • eISSN 2835-3315
Back to Top

Preoperative Evaluation of the Renal Function Before Kidney Cancer Surgery

Tao-Nong Cai, Jiang-Li Lu, Zi-Ke Qin, Yun-Lin Ye
  • Reset Zoom
  • Download TIFF